跳轉至內容
Merck
全部照片(3)

Key Documents

I5659

Sigma-Aldrich

艾地苯醌

≥98% (HPLC), powder

同義詞:

2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C19H30O5
CAS號碼:
分子量::
338.44
MDL號碼:
分類程式碼代碼:
12352204
PubChem物質ID:
NACRES:
NA.25

product name

艾地苯醌, ≥98% (HPLC)

化驗

≥98% (HPLC)

形狀

powder

溶解度

methanol: 50 mg/mL, clear to slightly hazy

儲存溫度

room temp

SMILES 字串

O=C(C(OC)=C1OC)C(CCCCCCCCCCO)=C(C)C1=O

InChI

1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3

InChI 密鑰

JGPMMRGNQUBGND-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

艾地苯醌是一种短链苯醌类药物。

應用

艾地苯醌已用于:
  • 处理用于药物治疗测定的突变肌纤蛋白 (mMYOC)细胞
  • 验证 C2C12 二次细胞筛选测定
  • 处理肥胖小鼠,测试艾地苯醌和 CoQ10 是否直接结合过氧化物酶体增殖物激活受体(PPAR)LBD、His 标记的 PPAR αδ 和γ LBD。

生化/生理作用

艾地苯醌用于治疗患有 Leber′遗传性视神经病变 (LHON)的青少年和成人的视力障碍。它可用作抗氧化剂。它有助于保护心肌免于氧化应激。
一种短链辅酶 Q 类似物,可通过介导电子从 N2 转移到氧来增强超氧化物的形成。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Idebenone maintains survival of mutant myocilin cells by inhibiting apoptosis
Guan Y, et al.
Chinese Medicine, 129(16), 2001-2001 (2016)
Mary Kearney et al.
The Cochrane database of systematic reviews, 4(4), CD007791-CD007791 (2012-04-20)
Friedreich ataxia is a rare inherited autosomal recessive neurological disorder, characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis and pes
Lucia Montenegro et al.
Molecular pharmaceutics, 9(9), 2534-2541 (2012-08-17)
The knowledge of the interactions between solid lipid nanoparticles (SLN) and cell membranes is important to develop effective carrier systems for drug delivery applications. Loading idebenone (IDE), an antioxidant drug useful in the treatment of neurodegenerative diseases, into SLN improves
Visual improvement with the use of idebenone in the treatment of Wolfram syndrome.
Simon R Bababeygy et al.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 32(4), 386-389 (2012-12-01)
Ruth Goldschmidt et al.
Bioorganic & medicinal chemistry, 21(4), 969-978 (2013-01-15)
Two new aza analogues of the neuroprotective agent idebenone have been synthesized and characterized. Their antioxidant activity, and ability to augment ATP levels have been evaluated in several different cell lines having suboptimal mitochondrial function. Both compounds were found to

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務